当前位置: X-MOL 学术Mol. Pharmaceutics › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
MicroRNA-203 Increases Cell Radiosensitivity via Directly Targeting Bmi-1 in Hepatocellular Carcinoma
Molecular Pharmaceutics ( IF 4.9 ) Pub Date : 2018-06-15 00:00:00 , DOI: 10.1021/acs.molpharmaceut.8b00302
Yingjie Shao 1 , Dachuan Zhang 1, 2 , Xiaodong Li 1, 2 , Jing Yang 1, 2 , Lujun Chen 1, 2 , Zhonghua Ning 1 , Yun Xu 1, 2 , Guohua Deng 1, 2 , Min Tao 2 , Yibei Zhu 2 , Jingting Jiang 1, 2
Affiliation  

Background: B-cell-specific moloney leukemia virus insertion site 1 (Bmi-1) plays important roles in various cancers, but its regulation through microRNAs (miRNAs) and its functions in hepatocellular carcinoma (HCC) remains unclear. Methods: We evaluated the expression and prognostic significance of Bmi-1 in HCC by using tissue samples and The Cancer Genome Atlas (TCGA) data sets. The relationship between miRNAs and Bmi-1 was verified by bioinformatics prediction and immunofluorescence. Colony formation and apoptosis assays were used to reveal the effect of miR-203 on radiosensitivity. Results: The Bmi-1 mRNA and protein were upregulated in HCC tissues. Cox regression multivariate analyses showed that Bmi-1 overexpression was an independent prognostic parameter for HCC patients. The expression level of Bmi-1 was negatively associated with miR-203 levels in HCC tissues. Dual-luciferase reporter assays showed that miR-203 could target the 3′ untranslated region (3′-UTR) of Bmi-1 directly. Overexpression of miR-203 in HepG2 and Smmc-7721 cells increases their sensitivity to ionizing radiation in vitro and in vivo. Moreover, the improved cell radiosensitivity induced by miR-203 could be rescued by restoration of Bmi-1 expression. Conclusions: Bmi-1 could improve the predictive accuracy for HCC patients’ survival. Moreover, miR-203 enhance cell radiosensitivity in vitro and in vivo by targeting Bmi-1 in HCC.

中文翻译:

MicroRNA-203通过直接靶向肝细胞癌中的Bmi-1增加细胞放射敏感性

背景:B细胞特异性单株白血病病毒插入位点1(Bmi-1)在各种癌症中起着重要作用,但其通过microRNA(miRNA)的调控及其在肝细胞癌(HCC)中的功能仍不清楚。方法:我们通过使用组织样本和癌症基因组图谱(TCGA)数据集评估了Bmi-1在肝癌中的表达和预后意义。通过生物信息学预测和免疫荧光验证了miRNA与Bmi-1之间的关系。使用菌落形成和凋亡测定法来揭示miR-203对放射敏感性的影响。结果:肝癌组织中Bmi-1 mRNA和蛋白上调。Cox回归多元分析表明,Bmi-1过表达是HCC患者的独立预后参数。Bmi-1的表达水平与肝癌组织中的miR-203水平呈负相关。双重荧光素酶报告基因测定表明,miR-203可以直接靶向Bmi-1的3'非翻译区(3'-UTR)。miR-203在HepG2和Smmc-7721细胞中的过表达增加了它们在体外和体内对电离辐射的敏感性。此外,可以通过恢复Bmi-1表达来挽救miR-203诱导的改善的细胞放射敏感性。结论:Bmi-1可以提高肝癌患者生存的预测准确性。而且,miR-203通过靶向HCC中的Bmi-1增强体外和体内细胞的放射敏感性。miR-203在HepG2和Smmc-7721细胞中的过表达增加了它们在体外和体内对电离辐射的敏感性。此外,可以通过恢复Bmi-1表达来挽救miR-203诱导的改善的细胞放射敏感性。结论:Bmi-1可以提高肝癌患者生存的预测准确性。而且,miR-203通过靶向HCC中的Bmi-1增强体外和体内细胞的放射敏感性。miR-203在HepG2和Smmc-7721细胞中的过表达增加了它们在体外和体内对电离辐射的敏感性。此外,可以通过恢复Bmi-1表达来挽救miR-203诱导的改善的细胞放射敏感性。结论:Bmi-1可以提高肝癌患者生存的预测准确性。而且,miR-203通过靶向HCC中的Bmi-1增强体外和体内细胞的放射敏感性。
更新日期:2018-06-15
down
wechat
bug